{"id":6430,"date":"2023-10-28T16:37:21","date_gmt":"2023-10-28T16:37:21","guid":{"rendered":"https:\/\/infundpros.com\/investment\/abbvies-humira-sales-sink-36-but-guidance-lifted-on-growth-from-other-drugs\/"},"modified":"2023-10-28T16:37:22","modified_gmt":"2023-10-28T16:37:22","slug":"abbvies-humira-sales-sink-36-but-guidance-lifted-on-growth-from-other-drugs","status":"publish","type":"post","link":"https:\/\/infundpros.com\/?p=6430","title":{"rendered":"AbbVie&#8217;s Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"WP-BAR-0000783223\">\n<div data-layout=\"wrap\n              \" data-layout-mobile=\"\" class=\"\n        media-object\n        type-InsetMediaIllustration\n          wrap\n  article__inset\n        article__inset--type-InsetMediaIllustration\n          article__inset--wrap\n    article__inset--lead\n  \"><\/p>\n<p>        <!-- eventually when we know what this card will be we can change it and leave this one --><\/p>\n<figure class=\"\n        media-object-image\n        enlarge-image\n        img-wrap\n        article__inset__image\n      \" itemscope=\"\" itemtype=\"http:\/\/schema.org\/ImageObject\"><\/p>\n<div style=\"padding-bottom:66.66666666666666%;\" data-subtype=\"photo\" class=\"image-container  responsive-media article__inset__image__image\"><\/div>\n<\/figure><\/div>\n<p>\n        AbbVie<br \/>\n       posted better-than-expected third-quarter earnings and revenue, raised its profit forecast for fiscal 2023 earnings, and increased its dividend. The stock was falling anyway.<\/p>\n<p>\n        AbbVie<br \/>\n       (ticker: ABBV) reported third-quarter earnings of $2.95 a share from revenue of $13.93 billion. Analysts surveyed by FactSet were expecting the biopharmaceuticals maker to post earnings of $2.87 a share from revenue of $13.72 billion.<\/p>\n<div class=\"paywall\">\n<p>In the same period last year, the company posted earnings of $3.66 a share from revenue of $14.81 billion.<\/p>\n<p>\u201cWe delivered another quarter of outstanding results driven by accelerating performance across our non-Humira growth platform, which is demonstrating double-digit growth,\u201d Chief Executive Richard Gonzalez said in a press release.<\/p>\n<p>Global revenue for Humira, used for conditions like rheumatoid arthritis and plaque psoriasis, came in at\u00a0$3.55 billion, down 36% from the prior year. But two other drugs in the company\u2019s immunology segment, Skyrizi and Rinvoq, achieved revenue gains of 52% and 59%, respectively. <\/p>\n<p>\n        AbbVie<br \/>\n       is now forecasting fiscal 2023 earnings of between $11.19 and $11.23 a share, compared with its previous call of $10.86 to $11.06. It increased the quarterly dividend to $1.55 from $1.48.<\/p>\n<p>Still, AbbVie stock was down 4.3% to $139.03, leaving it on pace for the largest percentage decrease since April 27 and th lowest close since July 19, according to Dow Jones Market Data. The stock has fallen 14% this year, and is on pace for its worst year on record. <\/p>\n<p>Write to Angela Palumbo at angela.palumbo@dowjones.com<\/p>\n<\/p><\/div>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/articles\/abbvie-humira-sales-earnings-ad0387bb?mod=investing\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AbbVie posted better-than-expected third-quarter earnings and revenue, raised its profit forecast for fiscal 2023 earnings, and increased its dividend. The stock was&#8230;<\/p>\n","protected":false},"author":1,"featured_media":6431,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":{"0":"post-6430","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investment"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AbbVie&#039;s Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs | inFundPros<\/title>\n<meta name=\"description\" content=\"AbbVie posted better-than-expected third-quarter earnings and revenue, raised its profit forecast for fiscal 2023 earnings, and increased its dividend.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/infundpros.com\/?p=6430\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AbbVie&#039;s Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs | inFundPros\" \/>\n<meta property=\"og:description\" content=\"AbbVie posted better-than-expected third-quarter earnings and revenue, raised its profit forecast for fiscal 2023 earnings, and increased its dividend.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/infundpros.com\/?p=6430\" \/>\n<meta property=\"og:site_name\" content=\"inFundPros\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-28T16:37:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-28T16:37:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/1698511041_social.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Press Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Press Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/infundpros.com\/?p=6430#article\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/?p=6430\"},\"author\":{\"name\":\"Press Room\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\"},\"headline\":\"AbbVie&#8217;s Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs\",\"datePublished\":\"2023-10-28T16:37:21+00:00\",\"dateModified\":\"2023-10-28T16:37:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/infundpros.com\/?p=6430\"},\"wordCount\":240,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"articleSection\":[\"Investment\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/infundpros.com\/?p=6430#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/infundpros.com\/?p=6430\",\"url\":\"https:\/\/infundpros.com\/?p=6430\",\"name\":\"AbbVie's Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs | inFundPros\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/#website\"},\"datePublished\":\"2023-10-28T16:37:21+00:00\",\"dateModified\":\"2023-10-28T16:37:22+00:00\",\"description\":\"AbbVie posted better-than-expected third-quarter earnings and revenue, raised its profit forecast for fiscal 2023 earnings, and increased its dividend.\",\"breadcrumb\":{\"@id\":\"https:\/\/infundpros.com\/?p=6430#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/infundpros.com\/?p=6430\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/infundpros.com\/?p=6430#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/infundpros.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AbbVie&#8217;s Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/infundpros.com\/#website\",\"url\":\"https:\/\/infundpros.com\/\",\"name\":\"Fintech Advance\",\"description\":\"Latest Finance and Tech News and Updates\",\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/infundpros.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/infundpros.com\/#organization\",\"name\":\"Fintech Advance\",\"url\":\"https:\/\/infundpros.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"width\":409,\"height\":70,\"caption\":\"Fintech Advance\"},\"image\":{\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\",\"name\":\"Press Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"caption\":\"Press Room\"},\"sameAs\":[\"https:\/\/infundpros.com\"],\"url\":\"https:\/\/infundpros.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AbbVie's Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs | inFundPros","description":"AbbVie posted better-than-expected third-quarter earnings and revenue, raised its profit forecast for fiscal 2023 earnings, and increased its dividend.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/infundpros.com\/?p=6430","og_locale":"en_US","og_type":"article","og_title":"AbbVie's Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs | inFundPros","og_description":"AbbVie posted better-than-expected third-quarter earnings and revenue, raised its profit forecast for fiscal 2023 earnings, and increased its dividend.","og_url":"https:\/\/infundpros.com\/?p=6430","og_site_name":"inFundPros","article_published_time":"2023-10-28T16:37:21+00:00","article_modified_time":"2023-10-28T16:37:22+00:00","og_image":[{"width":1280,"height":640,"url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/1698511041_social.jpeg","type":"image\/jpeg"}],"author":"Press Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Press Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/infundpros.com\/?p=6430#article","isPartOf":{"@id":"https:\/\/infundpros.com\/?p=6430"},"author":{"name":"Press Room","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff"},"headline":"AbbVie&#8217;s Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs","datePublished":"2023-10-28T16:37:21+00:00","dateModified":"2023-10-28T16:37:22+00:00","mainEntityOfPage":{"@id":"https:\/\/infundpros.com\/?p=6430"},"wordCount":240,"commentCount":0,"publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"articleSection":["Investment"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/infundpros.com\/?p=6430#respond"]}]},{"@type":"WebPage","@id":"https:\/\/infundpros.com\/?p=6430","url":"https:\/\/infundpros.com\/?p=6430","name":"AbbVie's Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs | inFundPros","isPartOf":{"@id":"https:\/\/infundpros.com\/#website"},"datePublished":"2023-10-28T16:37:21+00:00","dateModified":"2023-10-28T16:37:22+00:00","description":"AbbVie posted better-than-expected third-quarter earnings and revenue, raised its profit forecast for fiscal 2023 earnings, and increased its dividend.","breadcrumb":{"@id":"https:\/\/infundpros.com\/?p=6430#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/infundpros.com\/?p=6430"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/infundpros.com\/?p=6430#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/infundpros.com\/"},{"@type":"ListItem","position":2,"name":"AbbVie&#8217;s Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs"}]},{"@type":"WebSite","@id":"https:\/\/infundpros.com\/#website","url":"https:\/\/infundpros.com\/","name":"Fintech Advance","description":"Latest Finance and Tech News and Updates","publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/infundpros.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/infundpros.com\/#organization","name":"Fintech Advance","url":"https:\/\/infundpros.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","width":409,"height":70,"caption":"Fintech Advance"},"image":{"@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff","name":"Press Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/person\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","caption":"Press Room"},"sameAs":["https:\/\/infundpros.com"],"url":"https:\/\/infundpros.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/6430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6430"}],"version-history":[{"count":1,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/6430\/revisions"}],"predecessor-version":[{"id":6432,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/6430\/revisions\/6432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/media\/6431"}],"wp:attachment":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}